Compass Therapeutics Stock In The News

CMPX Stock  USD 2.70  0.08  2.88%   
Our overall analysis of Compass Therapeutics' news coverage and content from conventional and social sources shows investors' bearish mood towards Compass Therapeutics. The specific impact of Compass Therapeutics news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Compass Therapeutics' overall financial health and prospects. It also depends on the type and quality of a news publisher. Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Compass Therapeutics headlines in addition to utilizing other, more conventional financial analysis modules. Check out Compass Therapeutics Backtesting and Compass Therapeutics Hype Analysis.
For more information on how to buy Compass Stock please use our How to Invest in Compass Therapeutics guide.

Compass Therapeutics Today Top News and Investor Outlook

Macroaxis News: globenewswire.com
Compass Therapeutics to Present Second Quarter Financial Results and Provide Business Update on August 11, 2025
https://www.globenewswire.com/news-release/2025/08/08/3130354/0/en/Compass-Therapeutics-to-Present-Second-Quarter-Financial-Results-and-Provide-Business-Update-on-August-11-2025.html
 Bullish
Yahoo News
Stifel Keeps Buy Rating on Compass Therapeutics (CMPX)
https://finance.yahoo.com/news/stifel-keeps-buy-rating-compass-160939532.html
 Bullish
Yahoo News
Compass Therapeutics (CMPX) Gains Analyst Confidence with Promising Cancer Pipeline
https://finance.yahoo.com/news/compass-therapeutics-cmpx-gains-analyst-150308860.html
 Bullish
Yahoo News
Compass Therapeutics And 2 Other Promising Penny Stocks To Watch
https://finance.yahoo.com/news/compass-therapeutics-2-other-promising-120513837.html
 Bullish
Investing News at Macroaxis
Stifel reiterates Buy rating on Compass Therapeutics stock with $11 target
https://www.investing.com/news/analyst-ratings/stifel-reiterates-buy-rating-on-compass-therapeutics-stock-with-11-target-93CH-4134120
 Bullish
Macroaxis News: globenewswire.com
Compass Therapeutics Announces First Pat...
https://www.globenewswire.com/news-release/2025/04/21/3064600/0/en/Compass-Therapeutics-Announces-First-Patient-Dosed-in-an-Investigator-Sponsored-Trial-of-Tovecimig-in-the-First-Line-Setting-for-Patients-with-Biliary-Tract-Cancer.html
 Neutral
Macroaxis News: globenewswire.com
Compass Therapeutics to Participate in the Stifel 2025 Virtual Targeted Oncology Forum
https://www.globenewswire.com/news-release/2025/04/02/3054684/0/en/Compass-Therapeutics-to-Participate-in-the-Stifel-2025-Virtual-Targeted-Oncology-Forum.html
 Bullish
Yahoo News
12 Best Rising Penny Stocks To Buy
https://finance.yahoo.com/news/12-best-rising-penny-stocks-165636339.html
 Bullish
Macroaxis News: globenewswire.com
Compass Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update
https://www.globenewswire.com/news-release/2023/11/09/2777240/0/en/Compass-Therapeutics-Reports-Third-Quarter-2023-Financial-Results-and-Provides-Corporate-Update.html
 Neutral
Macroaxis News: globenewswire.com
Compass Therapeutics to Participate in Upcoming Investor Events
https://www.globenewswire.com/news-release/2023/11/07/2775057/0/en/Compass-Therapeutics-to-Participate-in-Upcoming-Investor-Events.html
 Bullish

Compass Therapeutics Past News Timeline

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Compass and other traded companies coverage with news coverage. We help investors stay connected with Compass headlines for the 9th of August to make an informed investment decision based on correlating the impacts of news items on Compass Stock performance. Please note that trading solely based on the Compass Therapeutics hype is not for everyone as timely availability and quick action are needed to avoid losses.
Compass Therapeutics' linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help Compass Therapeutics investors visualize upcoming and past events in order to time the market based on Compass Therapeutics noise-free hype analysis.

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Compass Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Compass Therapeutics' short interest history, or implied volatility extrapolated from Compass Therapeutics options trading.

Additional Tools for Compass Stock Analysis

When running Compass Therapeutics' price analysis, check to measure Compass Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Compass Therapeutics is operating at the current time. Most of Compass Therapeutics' value examination focuses on studying past and present price action to predict the probability of Compass Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Compass Therapeutics' price. Additionally, you may evaluate how the addition of Compass Therapeutics to your portfolios can decrease your overall portfolio volatility.